Inventor · disambiguated record
Vu Van Ma
Also filed as: MA VU · MA VU V · MA VU VAN
28 granted patents·9 pending applications·256 citations·filing 1998–2025
96Inventor score
Top patents by PatentIndex Score
37 records- 0198US11766436B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2021·Granted Sep 26, 2023·11 cites·19 claims
- 0298US11090304B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Aug 17, 2021·33 cites·3 claims
- 0396US12083121B2Substituted piperazines as KRAS G12C inhibitorsAMGEN INC·Filed 2022·Granted Sep 10, 2024·7 cites·5 claims
- 0496US11285156B2Substituted piperazines as KRAS G12C inhibitorsAMGEN INC·Filed 2019·Granted Mar 29, 2022·16 cites·4 claims
- 0596US9611261B2Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2015·Granted Apr 4, 2017·25 cites·40 claims
- 0695US11053226B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Jul 6, 2021·25 cites·48 claims
- 0795US9085576B2Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2014·Granted Jul 21, 2015·31 cites·60 claims
- 0894US8426447B2Spiro-tricyclic ring compounds as beta-secretase modulators and methods of useWHITE RYAN·Filed 2009·Granted Apr 23, 2013·58 cites·22 claims
- 0993US12440491B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2023·Granted Oct 14, 2025·1 cites·4 claims
- 1089US12054476B2KIF18A inhibitorsAMGEN INC·Filed 2021·Granted Aug 6, 2024·1 cites·31 claims
- 1188US2025381187A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2025·Application pending·0 cites
- 1285US12509442B2KIF18A inhibitorsAMGEN INC·Filed 2024·Granted Dec 30, 2025·0 cites·32 claims
- 1385US6310244B1Photocleavable and acid cleavable linkers for combinatorial chemistryPHARMACOPEIA INC·Filed 1998·Granted Oct 30, 2001·27 cites·5 claims
- 1482US9096527B2TRPM8 antagonists and their use in treatmentsAMGEN INC·Filed 2014·Granted Aug 4, 2015·5 cites·38 claims
- 1580US7439360B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Oct 21, 2008·3 cites·11 claims
- 1678US8026241B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2009·Granted Sep 27, 2011·3 cites·17 claims
- 1776US8883782B2Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of useCHENG YUAN·Filed 2011·Granted Nov 11, 2014·4 cites·18 claims
- 1875US12459932B2KIF18A inhibitorsAMGEN INC·Filed 2019·Granted Nov 4, 2025·1 cites·34 claims
- 1969US9550762B2Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2015·Granted Jan 24, 2017·1 cites·95 claims
- 2064US7582761B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2003·Granted Sep 1, 2009·2 cites·20 claims
- 2164US7514438B2Melanin concentrating hormone receptor antagonistAMGEN INC·Filed 2004·Granted Apr 7, 2009·2 cites·9 claims
- 2259US7659276B2Melanin concentrating hormone receptor antagonistAMGEN INC·Filed 2009·Granted Feb 9, 2010·0 cites·8 claims
- 2356US2023406860A1Heterocyclic spiro compounds and methods of useAMGEN INC·Filed 2021·Application pending·0 cites
- 2455US8710043B2TRPM8 antagonists and their use in treatmentsCHEN JIAN J·Filed 2012·Granted Apr 29, 2014·0 cites·40 claims
- 2555US2024059703A1Heterocyclic spiro compounds and methods of useAMGEN INC·Filed 2021·Application pending·0 cites
- 2652US12473289B2Heterocyclic compounds as delta-5 desaturase inhibitors and methods of useAMGEN INC·Filed 2020·Granted Nov 18, 2025·0 cites·10 claims
- 2752US2023159510A1Novel prmt5 inhibitorsAMGEN INC·Filed 2021·Application pending·0 cites
- 2851US2011118234A1Urea Compounds as Gamma Secretase ModulatorsBISWAS KAUSTAV·Filed 2009·Application pending·0 cites
- 2948US11279712B2Macrocyclic compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2018·Granted Mar 22, 2022·0 cites·21 claims
- 3048US10889581B2Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2017·Granted Jan 12, 2021·0 cites·21 claims
- 3148US2015031668A1Chroman derivatives as trpm8 inhibitorsAMGEN INC·Filed 2014·Application pending·0 cites
- 3247US2015252011A1Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2015·Application pending·0 cites
- 3346US8952009B2Chroman derivatives as TRPM8 inhibitorsAMGEN INC·Filed 2013·Granted Feb 10, 2015·0 cites·57 claims
- 3446US2017267673A1Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2016·Application pending·0 cites
- 3544US6642417B2Photocleavable and acid cleavable linkers for combinatorial chemistryPHARMACOPEIA DRUG DISCOVERY·Filed 2001·Granted Nov 4, 2003·0 cites·19 claims
- 3643US8476297B2TRP-M8 receptor ligands and their use in treatmentsNORMAN MARK H·Filed 2008·Granted Jul 2, 2013·0 cites·11 claims
- 3743US2005256161A1Melanin concentrating hormone receptor antagonistsTEMPEST PAUL A·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vu Van Ma files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →